Search results for: act pediatric trials network

Although the primary focus of this Contract is to support the Best Pharmaceuticals for Children Act-Pediatric Trials Network clinical activities, NICHD also anticipates the need to utilize this Contract to acquire similar types of support for other NICHD pediatric drug development activities.BPCA 2017 authorizes NICHD to identify therapeutic gaps in pediatrics, which are pediatric diseases, disorders or conditions where more complete knowledge and

2020.500-COVID-19 - BEST PHARMACEUTICALS FOR CHILDREN ACT PEDIATRIC TRIALS NETWORK - COVID-19 STUDIES Solicitation ID/Procurement Identifier: 75N94018D00003 Ultimate Completion Date: Wed Sep 20 17:00:00 GMT 2023

Contact Information: Angela Wish, Contract Specialist, Phone 301-435-6947, Email angela.wish@nih.gov - Alice M Pagan, Contract Specialist, Phone 301-435-6959, Email alice.pagan@nih.gov Office Address :Contracts Management Branch6710B Rockledge Dr., Suite 1124, MSC7000 Bethesda MD 20892-7510 Location: National Institute of Child Health and Human Development Set Aside: Award Number: HHSN275201800003I Award Amount : IDIQ Ceiling Amount - $96,000,000; Task Order 1 Amount - $1,014,917 Award Date: 060418 Awardee: Duke University, 2200 West Main Street, Suite 900, Durham, NC 27705 US